Soru

Zorluk: Çok zorGeneral Internal Medicine

A 52-year-old man is evaluated in the clinic for resistant hypertension. Despite adherence to a regimen of amlodipine, lisinopril, and chlorthalidone at maximum tolerated doses, his blood pressure remains poorly controlled at 168/102 mm Hg. He reports occasional muscle weakness but is otherwise asymptomatic. Laboratory studies reveal a serum potassium level of 3.1 mEq/L and a serum sodium level of 144 mEq/L. The physician suspects a secondary cause for his resistant hypertension. Arrange the following diagnostic steps in the most appropriate chronological order to definitively evaluate and subtype this patient's condition.

  1. 1Discontinue interfering antihypertensive medications and transition to permissive agents.
  2. 2Measure the plasma aldosterone concentration (PAC) and plasma renin activity (PRA) to calculate the PAC/PRA ratio.
  3. 3Perform a confirmatory biochemical suppression test (e.g., intravenous saline load).
  4. 4Obtain a high-resolution computed tomography (CT) scan of the adrenal glands.
  5. 5Perform bilateral adrenal venous sampling to determine lateralization of aldosterone hypersecretion.

Cevap

The correct chronological sequence is: 1) Discontinue interfering medications, 2) Measure the PAC/PRA ratio, 3) Perform a confirmatory suppression test, 4) Obtain an adrenal CT scan, 5) Perform bilateral adrenal venous sampling.
The evaluation of primary hyperaldosteronism must follow a strict algorithmic approach to prevent diagnostic errors and avoid unnecessary surgeries. First, interfering medications (especially ACE inhibitors, ARBs, and diuretics) must be discontinued because they alter renin and aldosterone levels, potentially causing false-negative screening results. Second, the initial screening is performed using the PAC/PRA ratio. Third, if the screen is positive, autonomous secretion must be confirmed with a suppression test (such as saline loading), as screening alone has a high false-positive rate. Fourth, once confirmed biochemically, an adrenal CT scan is obtained to identify macroscopic pathology and delineate venous anatomy. Finally, because non-functioning adrenal incidentalomas are highly prevalent, bilateral adrenal venous sampling is performed to definitively prove lateralization of aldosterone excess before committing the patient to a unilateral adrenalectomy.

Adım Adım Çözüm

1
Recognize the clinical presentation of suspected primary hyperaldosteronism.
Identify the need for a targeted, step-wise diagnostic workup.
Resistant hypertension combined with unprovoked or diuretic-induced hypokalemia is a classic presentation for mineralocorticoid excess.
2
Prepare the patient for biochemical screening by adjusting medications.
Transition from ACE inhibitors and diuretics to permissive agents like calcium channel blockers or alpha-blockers.
Diuretics and ACE inhibitors stimulate renin production, which can falsely lower the PAC/PRA ratio and lead to a false-negative screening result.
3
Perform the initial biochemical screening.
Measure the PAC/PRA ratio.
This is the most sensitive initial screening tool. A ratio >20 with a PAC >15 ng/dL suggests the diagnosis.
4
Confirm the diagnosis of autonomous aldosterone secretion.
Perform a suppression test, such as an intravenous saline infusion.
Screening tests have a high false-positive rate. Failure of aldosterone to suppress after a sodium load confirms autonomous production.
5
Classify the disease subtype using anatomical imaging.
Obtain a high-resolution adrenal CT scan.
Imaging helps identify macroscopic pathology, rules out large adrenal carcinomas, and maps the venous anatomy for subsequent invasive testing.
6
Differentiate unilateral adenoma from bilateral hyperplasia functionally.
Perform bilateral adrenal venous sampling (AVS).
Because adrenal incidentalomas are common in older adults, a CT scan alone cannot prove that a visible nodule is the source of excess aldosterone. AVS definitively identifies lateralization before committing the patient to a unilateral adrenalectomy.

Anahtar Kavram

The evaluation of primary hyperaldosteronism follows a strict sequence: Medication adjustment → Biochemical screening (PAC/PRA) → Biochemical confirmation (Suppression test) → Anatomical subtyping (CT scan) → Functional lateralization (Adrenal venous sampling).
Bu soruyu puanla